Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004
Purpose Understanding the completeness and accuracy of U.S. military anthrax vaccination data is important to the design and interpretation of studies to assess the safety of anthrax vaccine. We estimated the agreement between electronically recorded anthrax vaccination data in the Defense Medical S...
Gespeichert in:
Veröffentlicht in: | Pharmacoepidemiology and drug safety 2007-06, Vol.16 (6), p.605-611 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 611 |
---|---|
container_issue | 6 |
container_start_page | 605 |
container_title | Pharmacoepidemiology and drug safety |
container_volume | 16 |
creator | Payne, Daniel C. Rose Jr, Charles E. Aranas, Aaron Zhang, Yujia Tolentino, Herman Weston, Emily McNeil, Michael M. Ruscio, Bruce |
description | Purpose
Understanding the completeness and accuracy of U.S. military anthrax vaccination data is important to the design and interpretation of studies to assess the safety of anthrax vaccine. We estimated the agreement between electronically recorded anthrax vaccination data in the Defense Medical Surveillance System (DMSS) versus anthrax vaccination data ed from hardcopy medical charts in a representative sample of the U.S. military from 1998 to 2004.
Methods
Medical chart ions were conducted at 28 military treatment facilities for 4201 personnel. ed anthrax vaccination data for 1817 personnel, representing 7400 anthrax vaccine doses, were compared with electronically captured data in the DMSS from 1998 to 2004. Sensitivity, positive predictive value (PPV), specificity and negative predictive value (NPV) were calculated using weighted analyses.
Results
Weighted person‐level analysis revealed DMSS sensitivity = 93.8% (95%CI = 91.1, 95.8), specificity = 87.0% (79.0, 92.3), PPV = 85.6% (77.2, 91.3) and NPV = 94.5% (91.7, 96.4). Report of anthrax vaccination within a ±7 days window in both medical chart and DMSS electronic data had a sensitivity of 88.3% (85.4, 90.7) and a PPV of 86.6% (84.9, 88.2) in the vaccine dose‐level analysis.
Conclusions
These results support that anthrax vaccination data captured by the DMSS are adequate for post‐marketing surveillance investigations in the U.S. military and are of comparable quality to data captured by other vaccine safety databases. Copyright © 2007 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/pds.1395 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70601948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70601948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3575-ea9f7de254204180c0444491164980170365146f1eeb56dedaffa5d02662aee23</originalsourceid><addsrcrecordid>eNp1kMtKw0AUQAdRfINfILMSF6beSeaRWUqrVmhVqI-NMEyTGxzNo2YStX9vSoOunM0duIfD5RByxGDAAMLzReoHLNJig-wy0DpgQqjN1V9EQSyk3iF73r8BdDvNt8kOUzxSIVe75OXCe_S-wLKhVUZt2bzW9pt-2iRxpW1cVdLUNpa6kjavSEeYYemRTjF1ic3prK0_0eW5LROks6VvsDijTOs4CAH4AdnKbO7xsJ_75PHq8mE4DiZ31zfDi0mQREKJAK3OVIqh4CFwFkMCvHuaMcl1DExBJAXjMmOIcyFTTG2WWZFCKGVoEcNon5ysvYu6-mjRN6ZwPsHVWVi13iiQwDSPO_B0DSZ15X2NmVnUrrD10jAwq5KmK2lWJTv0uHe28wLTP7BP1wHBGvhyOS7_FZn70awX9rzrKn3_8rZ-N1JFSpjn22sjxnE8EdMncxv9AJT6icU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70601948</pqid></control><display><type>article</type><title>Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Payne, Daniel C. ; Rose Jr, Charles E. ; Aranas, Aaron ; Zhang, Yujia ; Tolentino, Herman ; Weston, Emily ; McNeil, Michael M. ; Ruscio, Bruce</creator><creatorcontrib>Payne, Daniel C. ; Rose Jr, Charles E. ; Aranas, Aaron ; Zhang, Yujia ; Tolentino, Herman ; Weston, Emily ; McNeil, Michael M. ; Ruscio, Bruce</creatorcontrib><description>Purpose
Understanding the completeness and accuracy of U.S. military anthrax vaccination data is important to the design and interpretation of studies to assess the safety of anthrax vaccine. We estimated the agreement between electronically recorded anthrax vaccination data in the Defense Medical Surveillance System (DMSS) versus anthrax vaccination data ed from hardcopy medical charts in a representative sample of the U.S. military from 1998 to 2004.
Methods
Medical chart ions were conducted at 28 military treatment facilities for 4201 personnel. ed anthrax vaccination data for 1817 personnel, representing 7400 anthrax vaccine doses, were compared with electronically captured data in the DMSS from 1998 to 2004. Sensitivity, positive predictive value (PPV), specificity and negative predictive value (NPV) were calculated using weighted analyses.
Results
Weighted person‐level analysis revealed DMSS sensitivity = 93.8% (95%CI = 91.1, 95.8), specificity = 87.0% (79.0, 92.3), PPV = 85.6% (77.2, 91.3) and NPV = 94.5% (91.7, 96.4). Report of anthrax vaccination within a ±7 days window in both medical chart and DMSS electronic data had a sensitivity of 88.3% (85.4, 90.7) and a PPV of 86.6% (84.9, 88.2) in the vaccine dose‐level analysis.
Conclusions
These results support that anthrax vaccination data captured by the DMSS are adequate for post‐marketing surveillance investigations in the U.S. military and are of comparable quality to data captured by other vaccine safety databases. Copyright © 2007 John Wiley & Sons, Ltd.</description><identifier>ISSN: 1053-8569</identifier><identifier>EISSN: 1099-1557</identifier><identifier>DOI: 10.1002/pds.1395</identifier><identifier>PMID: 17437247</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Adolescent ; Adult ; Aged ; anthrax vaccine ; anthrax vaccine adsorbed (AVA) ; Anthrax Vaccines - adverse effects ; Defense Medical Surveillance System (DMSS) ; Female ; Humans ; Male ; Medical Records ; Middle Aged ; Military Personnel ; military vaccination records ; post-marketing surveillance ; Product Surveillance, Postmarketing ; Time Factors ; Vaccination - adverse effects ; vaccine safety</subject><ispartof>Pharmacoepidemiology and drug safety, 2007-06, Vol.16 (6), p.605-611</ispartof><rights>Copyright © 2007 John Wiley & Sons, Ltd.</rights><rights>Copyright (c) 2007 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3575-ea9f7de254204180c0444491164980170365146f1eeb56dedaffa5d02662aee23</citedby><cites>FETCH-LOGICAL-c3575-ea9f7de254204180c0444491164980170365146f1eeb56dedaffa5d02662aee23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpds.1395$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpds.1395$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17437247$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Payne, Daniel C.</creatorcontrib><creatorcontrib>Rose Jr, Charles E.</creatorcontrib><creatorcontrib>Aranas, Aaron</creatorcontrib><creatorcontrib>Zhang, Yujia</creatorcontrib><creatorcontrib>Tolentino, Herman</creatorcontrib><creatorcontrib>Weston, Emily</creatorcontrib><creatorcontrib>McNeil, Michael M.</creatorcontrib><creatorcontrib>Ruscio, Bruce</creatorcontrib><title>Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004</title><title>Pharmacoepidemiology and drug safety</title><addtitle>Pharmacoepidem. Drug Safe</addtitle><description>Purpose
Understanding the completeness and accuracy of U.S. military anthrax vaccination data is important to the design and interpretation of studies to assess the safety of anthrax vaccine. We estimated the agreement between electronically recorded anthrax vaccination data in the Defense Medical Surveillance System (DMSS) versus anthrax vaccination data ed from hardcopy medical charts in a representative sample of the U.S. military from 1998 to 2004.
Methods
Medical chart ions were conducted at 28 military treatment facilities for 4201 personnel. ed anthrax vaccination data for 1817 personnel, representing 7400 anthrax vaccine doses, were compared with electronically captured data in the DMSS from 1998 to 2004. Sensitivity, positive predictive value (PPV), specificity and negative predictive value (NPV) were calculated using weighted analyses.
Results
Weighted person‐level analysis revealed DMSS sensitivity = 93.8% (95%CI = 91.1, 95.8), specificity = 87.0% (79.0, 92.3), PPV = 85.6% (77.2, 91.3) and NPV = 94.5% (91.7, 96.4). Report of anthrax vaccination within a ±7 days window in both medical chart and DMSS electronic data had a sensitivity of 88.3% (85.4, 90.7) and a PPV of 86.6% (84.9, 88.2) in the vaccine dose‐level analysis.
Conclusions
These results support that anthrax vaccination data captured by the DMSS are adequate for post‐marketing surveillance investigations in the U.S. military and are of comparable quality to data captured by other vaccine safety databases. Copyright © 2007 John Wiley & Sons, Ltd.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>anthrax vaccine</subject><subject>anthrax vaccine adsorbed (AVA)</subject><subject>Anthrax Vaccines - adverse effects</subject><subject>Defense Medical Surveillance System (DMSS)</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical Records</subject><subject>Middle Aged</subject><subject>Military Personnel</subject><subject>military vaccination records</subject><subject>post-marketing surveillance</subject><subject>Product Surveillance, Postmarketing</subject><subject>Time Factors</subject><subject>Vaccination - adverse effects</subject><subject>vaccine safety</subject><issn>1053-8569</issn><issn>1099-1557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKw0AUQAdRfINfILMSF6beSeaRWUqrVmhVqI-NMEyTGxzNo2YStX9vSoOunM0duIfD5RByxGDAAMLzReoHLNJig-wy0DpgQqjN1V9EQSyk3iF73r8BdDvNt8kOUzxSIVe75OXCe_S-wLKhVUZt2bzW9pt-2iRxpW1cVdLUNpa6kjavSEeYYemRTjF1ic3prK0_0eW5LROks6VvsDijTOs4CAH4AdnKbO7xsJ_75PHq8mE4DiZ31zfDi0mQREKJAK3OVIqh4CFwFkMCvHuaMcl1DExBJAXjMmOIcyFTTG2WWZFCKGVoEcNon5ysvYu6-mjRN6ZwPsHVWVi13iiQwDSPO_B0DSZ15X2NmVnUrrD10jAwq5KmK2lWJTv0uHe28wLTP7BP1wHBGvhyOS7_FZn70awX9rzrKn3_8rZ-N1JFSpjn22sjxnE8EdMncxv9AJT6icU</recordid><startdate>200706</startdate><enddate>200706</enddate><creator>Payne, Daniel C.</creator><creator>Rose Jr, Charles E.</creator><creator>Aranas, Aaron</creator><creator>Zhang, Yujia</creator><creator>Tolentino, Herman</creator><creator>Weston, Emily</creator><creator>McNeil, Michael M.</creator><creator>Ruscio, Bruce</creator><general>John Wiley & Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200706</creationdate><title>Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004</title><author>Payne, Daniel C. ; Rose Jr, Charles E. ; Aranas, Aaron ; Zhang, Yujia ; Tolentino, Herman ; Weston, Emily ; McNeil, Michael M. ; Ruscio, Bruce</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3575-ea9f7de254204180c0444491164980170365146f1eeb56dedaffa5d02662aee23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>anthrax vaccine</topic><topic>anthrax vaccine adsorbed (AVA)</topic><topic>Anthrax Vaccines - adverse effects</topic><topic>Defense Medical Surveillance System (DMSS)</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical Records</topic><topic>Middle Aged</topic><topic>Military Personnel</topic><topic>military vaccination records</topic><topic>post-marketing surveillance</topic><topic>Product Surveillance, Postmarketing</topic><topic>Time Factors</topic><topic>Vaccination - adverse effects</topic><topic>vaccine safety</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Payne, Daniel C.</creatorcontrib><creatorcontrib>Rose Jr, Charles E.</creatorcontrib><creatorcontrib>Aranas, Aaron</creatorcontrib><creatorcontrib>Zhang, Yujia</creatorcontrib><creatorcontrib>Tolentino, Herman</creatorcontrib><creatorcontrib>Weston, Emily</creatorcontrib><creatorcontrib>McNeil, Michael M.</creatorcontrib><creatorcontrib>Ruscio, Bruce</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacoepidemiology and drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Payne, Daniel C.</au><au>Rose Jr, Charles E.</au><au>Aranas, Aaron</au><au>Zhang, Yujia</au><au>Tolentino, Herman</au><au>Weston, Emily</au><au>McNeil, Michael M.</au><au>Ruscio, Bruce</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004</atitle><jtitle>Pharmacoepidemiology and drug safety</jtitle><addtitle>Pharmacoepidem. Drug Safe</addtitle><date>2007-06</date><risdate>2007</risdate><volume>16</volume><issue>6</issue><spage>605</spage><epage>611</epage><pages>605-611</pages><issn>1053-8569</issn><eissn>1099-1557</eissn><abstract>Purpose
Understanding the completeness and accuracy of U.S. military anthrax vaccination data is important to the design and interpretation of studies to assess the safety of anthrax vaccine. We estimated the agreement between electronically recorded anthrax vaccination data in the Defense Medical Surveillance System (DMSS) versus anthrax vaccination data ed from hardcopy medical charts in a representative sample of the U.S. military from 1998 to 2004.
Methods
Medical chart ions were conducted at 28 military treatment facilities for 4201 personnel. ed anthrax vaccination data for 1817 personnel, representing 7400 anthrax vaccine doses, were compared with electronically captured data in the DMSS from 1998 to 2004. Sensitivity, positive predictive value (PPV), specificity and negative predictive value (NPV) were calculated using weighted analyses.
Results
Weighted person‐level analysis revealed DMSS sensitivity = 93.8% (95%CI = 91.1, 95.8), specificity = 87.0% (79.0, 92.3), PPV = 85.6% (77.2, 91.3) and NPV = 94.5% (91.7, 96.4). Report of anthrax vaccination within a ±7 days window in both medical chart and DMSS electronic data had a sensitivity of 88.3% (85.4, 90.7) and a PPV of 86.6% (84.9, 88.2) in the vaccine dose‐level analysis.
Conclusions
These results support that anthrax vaccination data captured by the DMSS are adequate for post‐marketing surveillance investigations in the U.S. military and are of comparable quality to data captured by other vaccine safety databases. Copyright © 2007 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>17437247</pmid><doi>10.1002/pds.1395</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1053-8569 |
ispartof | Pharmacoepidemiology and drug safety, 2007-06, Vol.16 (6), p.605-611 |
issn | 1053-8569 1099-1557 |
language | eng |
recordid | cdi_proquest_miscellaneous_70601948 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adolescent Adult Aged anthrax vaccine anthrax vaccine adsorbed (AVA) Anthrax Vaccines - adverse effects Defense Medical Surveillance System (DMSS) Female Humans Male Medical Records Middle Aged Military Personnel military vaccination records post-marketing surveillance Product Surveillance, Postmarketing Time Factors Vaccination - adverse effects vaccine safety |
title | Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A11%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20anthrax%20vaccination%20data%20in%20the%20Defense%20Medical%20Surveillance%20System,%201998-2004&rft.jtitle=Pharmacoepidemiology%20and%20drug%20safety&rft.au=Payne,%20Daniel%20C.&rft.date=2007-06&rft.volume=16&rft.issue=6&rft.spage=605&rft.epage=611&rft.pages=605-611&rft.issn=1053-8569&rft.eissn=1099-1557&rft_id=info:doi/10.1002/pds.1395&rft_dat=%3Cproquest_cross%3E70601948%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70601948&rft_id=info:pmid/17437247&rfr_iscdi=true |